The drug Inlita (Axitinib) - Inlyta (Axitinib) 5 mg refers to tumor-fighting agents that inhibit protein tyrokinase. The active ingredient is Axitinib. In our Internet pharmacy, the most favorable price for Inlyta (Axitinib) - Inlyta (Axitinib) . Release form The drug is available in the form of tablets with a film-coated shell on the surface, with a dosage of 1 and 5 mg. The surface is engraved with "Pfizer". This serves as protection against counterfeiting. The tablets are oval red. Triangular shaped tablets with a dosage of 5 mg can be produced. Pharmacodynamics The drug belongs to antineoplastic agents that block tyrosine kinase. It is a potent selective inhibitor of this enzyme, which is involved in the growth mechanism of tumor cells. The drug interferes with phosphorylation processes, which leads to a slowdown in the growth of cell formations. Experimental models even managed to achieve regression. In our Internet pharmacy you can buy Inlyta (Axitinib) - Inlyta (Axitinib) inexpensively with home delivery.
Pharmacokinetics In blood plasma, the drug is found 4 hours after administration. In it, it lasts up to 4.1 hours. After a meal, absorption decreases by 10% compared to the fasting state. The drug metabolism occurs in the liver tissue. It is found unchanged in urine and feces. Indications for use The drug is used for the therapeutic correction of advanced renal cell carcinoma. It is used as a second-line therapy drug. Contraindications For a number of patients, the drug is contraindicated for use. These include the following conditions: • Cases of individual intolerance to the components of the drug. • Severe liver failure. • Have had arterial thromboembolism in the last 12 months. • Cases of venous thromboembolism in the previous 6 months. • Metastases in the brain without treatment. • Presence of gastrointestinal bleeding. • Pregnancy and lactation period. • Age up to 18 years (there is no data on the effect of the drug on this group of people). About the drug Inlita Axitinib 5 mg reviews in most cases are only positive.
©2020 CopyRight Onco24.com. All rights reserved.